IGF1 and acromegaly: The higher rate of comorbidities observed in elderly acromegalic patients with an early diagnosis (group 2, characterized by a longer duration of disease) than in those with acromegaly diagnosed after 65 years can be related to the prolonged exposure to GH and IGF-1 and to a late diagnosis, added to physiological aging.